# HAEMATO PHARM GmbH

Company profile · SME (from the award notice)

- Legal form: GmbH
- Seat: Schönefeld, Germany

Based on the notices and sources Inteliwert covers; not a complete record. Last checked 1 November 2024.

## Identifiers

- Register entry: HRB 11240 CB

As the covered sources state them.

## Track record in public tenders

Awards in the covered notices over the last 36 months, per CPV division.

| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
| --- | ---: | ---: | ---: | ---: | --- | --- |
| 33 Medical equipments, pharmaceuticals and personal care products | 1 | — | 1 | 0 | 1 November 2024 | 1 November 2024 |

Based on the notices and sources Inteliwert covers; not a complete record.

### Awards

- [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Interferon beta-1a (ausschl. zur subkutanen Anwendung), ATC L03AB07 für die Zeit 01.11.2024 - 31.10.2026](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi)  
  Buyer: DAK-Gesundheit · Awarded: 1 November 2024 · CPV 33600000

## Certifications and prequalification

No certification or prequalification found in the covered sources.

A certification missing here is unknown, not absent.

## Website and LinkedIn

Not found in the indexed notices.

## Open tenders that might fit

*Possible match based on public information*

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

- [Open-House-Rabattverträge 2026-21 Lisdexamfetamin (90 St.)](https://inteliwert.com/tender/opp_5V97787MV6AN17BB79FJWVV6FY/open-house-rabattvertraege-2026-21-lisdexamfetamin-90-st)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 31 Mar 2028, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/11d66e3b-2f29-4ea1-8371-be1eb4a372e6), Last checked 4 Nov 2026, 13:10 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-11-01): [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 1 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_HDH30PMZDH056TQJTY37KWHQMT), checked 1 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 1 Nov 2026
- [Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)](https://inteliwert.com/tender/opp_5711SQ0A41KDJ0AFBSAHAKZAYA/open-house-biologika-rabattvertraege-2026-29-rituximab-nur-fertigarzneimittel)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 30 Nov 2028, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/33b69167-7e60-418e-8bf6-f90ebe8602a5), Last checked 4 Nov 2026, 13:10 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-11-01): [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 2 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_HDH30PMZDH056TQJTY37KWHQMT), checked 2 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 2 Nov 2026
- [Open-House-Rabattverträge 2026-18](https://inteliwert.com/tender/opp_GRQNQKG4Q8X4MDE2SVYRKTM36W/open-house-rabattvertraege-2026-18)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 30 Nov 2028, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/a5313d67-c4f0-4bf7-95e5-eeca963d9c17), Last checked 28 Oct 2026, 06:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-11-01): [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 4 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_HDH30PMZDH056TQJTY37KWHQMT), checked 4 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 4 Nov 2026
- [Open-House-Rabattverträge 2026-19 Adalimumab](https://inteliwert.com/tender/opp_HEVJG3T9WK8N1PY8FBMFQ2WNRK/open-house-rabattvertraege-2026-19-adalimumab)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 31 Dec 2028, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/276c0bce-49f0-4eb3-8ef1-719d1e3a5c55), Last checked 4 Nov 2026, 16:10 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-11-01): [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 5 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_HDH30PMZDH056TQJTY37KWHQMT), checked 5 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 5 Nov 2026
- [Rahmenvereinbarung Lieferung von qPCR-Testkits zur molekularischen Diagnostik der Afrikanischen Schweinepest "ASP-PCR-Testkits"](https://inteliwert.com/tender/opp_X6S9QF7J01407APVCQT1N2SCT6/rahmenvereinbarung-lieferung-von-qpcr-testkits-zur-molekularischen-diagnostik-de)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Landeslabor Berlin-Brandenburg · Deadline: 30 Nov 2026, 12:00 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/a9c13299-897b-4ab0-a075-ee18148ed7c9), Last checked 4 Nov 2026, 15:10 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-11-01): [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 6 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_HDH30PMZDH056TQJTY37KWHQMT), checked 6 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 6 Nov 2026
- [Open House Biologika Rabattverträge 2026-32 Aflibercept](https://inteliwert.com/tender/opp_WSKGYA9ZND35F6W5E7WNV4AW17/open-house-biologika-rabattvertraege-2026-32-aflibercept)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 31 Dec 2028, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/60747ad7-e36b-4524-9446-19a5cbd1bc8d), Last checked 4 Nov 2026, 15:10 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-11-01): [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 6 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_HDH30PMZDH056TQJTY37KWHQMT), checked 6 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 6 Nov 2026
- [Open House Biologika Rabattverträge 2026 - 31 Ranibizumab](https://inteliwert.com/tender/opp_KMH2Q0FSGYKWKGYPB6RM6G8EYP/open-house-biologika-rabattvertraege-2026-31-ranibizumab)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 31 Dec 2028, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/409e389a-cedc-4c49-9865-2244b11e751c), Last checked 4 Nov 2026, 15:10 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-11-01): [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 6 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_HDH30PMZDH056TQJTY37KWHQMT), checked 6 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 6 Nov 2026
- [Lieferung von Impfstoffen und Diagnostika für den Öffentlichen Gesundheitsdienst und den Betriebsärztlichen Dienst des Landes Brandenburg im Jahr 2027](https://inteliwert.com/tender/opp_75N8260MNHTXAA9GMB5F7P1B6X/lieferung-von-impfstoffen-und-diagnostika-fuer-den-oeffentlichen-gesundheitsdien)  
  Open · SME (from the award notice) · New to public tenders · Deadline: 23 Nov 2026, 13:00 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/3dd5c17cbee45d44), Last checked 30 Oct 2026, 05:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-11-01): [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 6 Nov 2026
  - Seat in the same federal state as the place of performance: [Evidence](https://inteliwert.com/company/org_HDH30PMZDH056TQJTY37KWHQMT), checked 6 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 6 Nov 2026
- [Beschaffung eines HR-pQCT-Systems](https://inteliwert.com/tender/opp_0DBGZQ921TT8J3X18FAN1D2TPP/beschaffung-eines-hr-pqct-systems)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Medizinische Universität Lausitz - Carl Thiem KdöR · Deadline: 1 Dec 2026, 10:00 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/eafd86f1-7455-4e86-88eb-a610aec44c0f), Last checked 4 Nov 2026, 13:10 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-11-01): [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 1 Nov 2026
  - Seat in the same region as the place of performance: [Evidence](https://inteliwert.com/company/org_HDH30PMZDH056TQJTY37KWHQMT), checked 1 Nov 2026
  - The buyer calls this tender suitable for SMEs, and the company is an SME: [Evidence](https://inteliwert.com/tender/opp_0DBGZQ921TT8J3X18FAN1D2TPP/beschaffung-eines-hr-pqct-systems), checked 1 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 1 Nov 2026
- [Open-House-Rabattverträge 2026-11 - Dorzolamid ATR (EDO)](https://inteliwert.com/tender/opp_EAR3F2QD6VBKMCAFYWF8PPDR1A/open-house-rabattvertraege-2026-11-dorzolamid-atr-edo)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 31 Oct 2026, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/fe11bdeb-4bff-4a53-a695-e0636ef2b1fb), Last checked 27 Oct 2026, 07:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2024-11-01): [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 3 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_HDH30PMZDH056TQJTY37KWHQMT), checked 3 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_KYSQ75RGYAJKNKBZW15KK3C2JH/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 3 Nov 2026

## Is this your company?

Send corrections, or ask us to remove the profile, to <hello@inteliwert.com>. You can also ask that the company never be tagged on LinkedIn.

## About this profile

Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.

**Based on the notices and sources Inteliwert covers; not a complete record.** Last checked 1 November 2024.

---

Page: https://inteliwert.com/company/org_HDH30PMZDH056TQJTY37KWHQMT/haemato-pharm-gmbh

Inteliwert is a product of Bandpey GmbH, an international data and AI software company in Munich, Germany, founded and led by Roozbeh Bandpey. Bandpey's products: Facthory, Emolysis, Copolly and Inteliwert.

Inteliwert on LinkedIn: https://www.linkedin.com/company/intelliwert, GitHub: https://github.com/inteliwertai.